References
- S. G. Abdel-Moty, M. H. Abdel-Rahman, H. A. Elsherief and A. H. N. Kafafy, Synthesis of some quinoline thiosemicarbazone derivatives of potential antimicrobial activity, Bull. Pharm. Sci. (Assiut University) 28 (2005) 79-93.
- R. Vlahov, St. Parushev, J. Vlahov, P. Nickel and G. Snatzke, Synthesis of some new quinoline derivatives - potential antimalarial drugs, Pure Appl. Chem. 62 (1990) 1303-1306; DOI: 10.1351/pac199062071303.
- M. Normand-Bayle, C. Bénard, V. Zouhiri, J. Mouscadet, H. Leh, C. Thomas, G. Mbemba, D. Desmaële and J. d'Angelo, New HIV-1 replication inhibitors of the styryquinoline class bearing aroyl/acyl groups at the C-7 position: synthesis and biological activity, Bioorg. Med. Chem. Lett. 15 (2005) 4019-4022; DOI: 10.1016/j.bmcl.2005.06.036.
- S. T. Hazeldine, L. Polin, J. Kushner, K. White, T. H. Corbett, J. Biehl and J. P. Horwitz, Part 3: Synthesis and biological evaluation of some analogs of the antitumor agents, 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid, and 2-{4-[7-bromo-2-quinolinyl)-oxy]phenoxy}propionic acid, Bioorg. Med. Chem. 13 (2005) 1069-1081, DOI: 10.1016/j.bmc.2004.11.034.
- J. He, L. Yun, R. Yang, Z. Xiao, J. Cheng, W. Zhou and Y. Zhang, Design, synthesis, and biological evaluation of novel 4-hydro-quinoline-3-carboxamide derivatives as an immunomodulator, Bioorg. Med. Chem. Lett. 15 (2005) 2980-2985; DOI: 10.1016/j.bmcl.2005.04.040.
- D. V. Kravchenko, V. V. Kysil, A. P. Ilyn, S. E. Tkachenko, S. Maliarchouk, I. M. Okun and A. V. Ivachtchenko, 1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent caspase-3 inhibitors, Bioorg. Med. Chem. Lett. 15 (2005) 1841-1845; DOI: 10.1016/j.bmcl.2005.02.027.
- Z. Dardari, M. Lemrani, A. Bahloul, A. Sebban, M. Hassar, S. Kitane, M. Berrada and M. Boudouma, Antileishmanial activity of a new 8-hydroxyquinoline derivative designed 7-[5-(3'-phenylisoxazolino)methyl]-8-hydroxyquinoline: preliminary study, Farmaco 59 (2004) 195-199; DOI: 10.1016/j.farmac.2003.11.001.
- F. E. Goda, A. A. Abdel-Aziz and H. A. Ghoneim, Synthesis and biological evaluation of novel 6-nitro-5-substituted aminoquinolines as local anesthetic and anti-arrhythmic agents: molecular modeling study, Bioorg. Med. Chem. 13 (2005) 3175-3183; DOI: 10.1016/j.bmc.2005.02.050.
- L. Savini, L. Chiasserini, C. Pellerano, W. Filippelli and G. Falcone, Synthesis and pharmacological activity of 1,2,4-triazolo[4,3-a]quinolines, Farmaco 56 (2001) 939-945; DOI: 10.1016/S0014-827X(01)01166-1.
- A. M. Omar, I. C. Ahmed, A. M. Hassan, O. M. AboulWafa, H. Abou-Shleib and K. A. Ismail, Synthesis and evaluation for antibacterial and antifungal activities of new 1-phenylhydrazono-2-(substituted thiocarbamoyl)hydrazonopyruvaldehyde and the corres- ponding thiazoline and thiazolidinone derivatives, Alex. J. Pharm. Sci. 4 (1990) 182-186.
- D. L. Klayman, J. P. Scovill, J. Bruce and J. F. Bartosevich, 2-Acetylpyridine thiosemicarbazones, 8. Derivatives of 1-acetylisoquinoline as potential antimalarial agents, J. Med. Chem. 27 (1984) 84-87; DOI: 10.1021/jm00367a018.
- S. Sharma, F. Athar, M. R. Maurya, F. Naqvi and A. Azam, Novel bidentate complexes of Cu(II) derived from 5-nitrofuran-2-carboxaldehyde thiosemicarbazones with antiamoebic activity against E. histolytica, Eur. J. Med. Chem. 40 (2005) 557-562, DOI: 10.1016/j. ejmech.2005.01.003.
- H. Y. Hassan, Synthesis and chelating properties of substituted formyl pyridine thiosemicarbazones of potential biological activity, Bull. Pharm. Sci. (Assiut University) 22 (1999) 97-108.
- S. M. Sondhi, N. Singh, A. M. Lahoti, K. Bajaj, A. Kumar, O. Lozach and L. Meijer, Synthesis of acridinyl-thiazolino derivatives and their evaluation for anti-inflammatory, analgesic and kinase inhibition activities, Bioorg. Med. Chem. 13 (2005) 4291-4299; DOI: 10.1016/j.bmc.2005.04.017.
- G. Mahler, G. Serra, S. Dematteis, J. Saldaña, L. Domínguez and E. Manta, Synthesis and biological evaluation of simplified mycothiazole analogues, Bioorg. Med. Chem. Lett. 16 (2006) 1309-1311; DOI: 10.1016/j.bmcl.2005.11.072.
- M. Shih and F. Ke, Synthesis and evaluation of antioxidant activity of sydnonyl substituted thiazolidinone and thiazoline derivatives, Bioorg. Med. Chem. 12 (2004) 4633-4643; DOI: 10.1016/j.bmc.2004.06.033.
- D. Barton and W. D. Ollis, Comprehensive Organic Chemistry (Ed. D. N. Jones), Vol. 3, Pergamon Press, New York 1979, p. 453.
- A. I. Vogel, A. R. Tatchell, B. S. Furnis, A. J. Hannaford, P. W. G. Smith, Vogel's Textbook of Practical Organic Chemistry, 5th ed, Harlow Pearson Ed. Ltd. 1989, p. 1052.
- W. Hewitt, An Introduction to Quantitative Principles and Evaluation, in Microbiological Assay, Academic Press, New York 1977.
- B. Tan, Guidelines on the Care and Use of Animals for Scientific Purposes, National Advisory Committee for Laboratory Animals, Singapore 2004.
- L. V. Nargund, G. R. Reddy and V. Hariprasad, Anti-inflammatory activity of substituted 1,3,4-oxadiazoles, J. Pharm. Sci. 83 (1994) 246-248; DOI: 10.1002/jps.2600830226.
- H. Ikuta, H. Shirota, S. Kobayashi, Y. Yamagishi, K. Yamada, I. Yamatsu and K. Katayama, Synthesis and anti-inflammatory activities of 3-(3,5-di-tert-butyl-4-hydroxybenzylidene)pyrrolidin-2-ones, J. Med. Chem. 30 (1987) 1995-1998.
- F. Sztaricskai, I. E. Takács, F. Pusztai, G. Szabó and I. Csípõ, Antiulcer effect of the N-and O-β-D-glucopyranosides of 5-aminosalicylic acid, Arch. Pharm. Pharm. Med. Chem. 332 (1999) 321-326.
- J. Leo, Calculating log Poct from structures, Chem. Rev. 93 (1993) 1281-1306; DOI: 10.1021/cr00020a001.
- G. Dannhardt, W. Kiefer, G. Krämer, S. Maehrlein, U. Nowe and B. Fiebich, The pyrrole moiety as a template for Cox-1/Cox-2 inhibitors, Eur. J. Med. Chem. 35 (2000) 499-510; DOI: 10.1016/S0223-5234(00)00150-1.
- M. J. O'Neil, A. Smith, P. E. Heckelman and S. Budavari (Eds), The Merck Index:, 13th ed, Merck Inc., Whitehouse Station (NJ) 2001, p. 892.